Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (11-20 of 393) with videos related to

Pageof 40
Sort By:
Clinical Pharmacology : Advances and Applications|December 23, 2017
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcomaAlexandra Pender, Robin L Jones
Journal of Surgical Oncology|December 2, 2017
Systemic therapy in retroperitoneal sarcoma managementAnastasia Constantinidou, Robin L Jones
Cancer|March 16, 2017
Q-TWiST: What really matters to the cancer patient?Olga Husson, Robin L Jones
Cancer Biology & Medicine|October 24, 2023
Recent advances in the systemic treatment of gastrointestinal stromal tumorsRobin L Jones, Marin Golčić
Future Oncology (London, England)|July 27, 2017
Olaratumab for the treatment of soft-tissue sarcomaAlexandra Pender, Robin L Jones
Future Oncology (London, England)|August 18, 2023
Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trialMarina Symcox, Robin L Jones
GMS Ophthalmology Cases|September 15, 2016
The management of ophthalmic involvement in blue rubber bleb nevus syndromeBradley Petek, Robin L Jones
JAMA Oncology|February 1, 2019
Treatment of Desmoid Tumors in 2019Alessandro Gronchi, Robin L Jones
JAMA Oncology|June 8, 2018
The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and TrunkAlessandro Gronchi, Robin L Jones
The Lancet. Oncology|October 3, 2006
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour responseRobin L Jones, Ian E Smith
Pageof 40

Showing results (11-20 of 393) with videos related to

Sort By:
Pageof 40
Clinical Pharmacology : Advances and Applications|December 23, 2017
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcomaAlexandra Pender, Robin L Jones
Journal of Surgical Oncology|December 2, 2017
Systemic therapy in retroperitoneal sarcoma managementAnastasia Constantinidou, Robin L Jones
Cancer|March 16, 2017
Q-TWiST: What really matters to the cancer patient?Olga Husson, Robin L Jones
Cancer Biology & Medicine|October 24, 2023
Recent advances in the systemic treatment of gastrointestinal stromal tumorsRobin L Jones, Marin Golčić
Future Oncology (London, England)|July 27, 2017
Olaratumab for the treatment of soft-tissue sarcomaAlexandra Pender, Robin L Jones
Future Oncology (London, England)|August 18, 2023
Ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor after treatment with imatinib: a plain language summary of the phase 3 INTRIGUE trialMarina Symcox, Robin L Jones
GMS Ophthalmology Cases|September 15, 2016
The management of ophthalmic involvement in blue rubber bleb nevus syndromeBradley Petek, Robin L Jones
JAMA Oncology|February 1, 2019
Treatment of Desmoid Tumors in 2019Alessandro Gronchi, Robin L Jones
JAMA Oncology|June 8, 2018
The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and TrunkAlessandro Gronchi, Robin L Jones
The Lancet. Oncology|October 3, 2006
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour responseRobin L Jones, Ian E Smith
Pageof 40